Peptide Lab HQ Research Guide
Chonluten
A research-focused compound profile covering Chonluten identity, EDG tripeptide research, respiratory tissue model context, bronchial mucosa research, concentration reference, preparation reference, and safety considerations.
Compound Data
Compound Profile
| Compound Name | Chonluten |
|---|---|
| Common Research Name | T-34 tripeptide / EDG tripeptide |
| Common Synonyms | Glu-Asp-Gly, Glutamyl-aspartyl-glycine, H-Glu-Asp-Gly-OH, T-34 peptide, EDG peptide |
| Compound Type | Synthetic ultrashort tripeptide / peptide bioregulator research compound |
| CAS Number | 75007-24-8; verify against supplier COA |
| PubChem CID | 194641 |
| Amino Acid Length | 3 amino acids |
| Amino Acid Sequence | Glu-Asp-Gly |
| Short Sequence | EDG |
| Molecular Formula | C₁₁H₁₇N₃O₈; verify against supplier COA |
| Molecular Weight | Approximately 319.27 g/mol; verify against supplier COA |
| Research Category | Peptide bioregulator, respiratory tissue model, bronchial mucosa, pulmonary epithelial, inflammatory signaling, antioxidant-response, and gene-expression research |
| Research Context | Commonly discussed in peptide bioregulator research involving lung and bronchial mucosa cell function, inflammatory-response pathways, antioxidant protein expression, and tissue-specific signaling models. |
| Appearance | White to off-white lyophilized powder, depending on supplier documentation |
| Use | For laboratory research use only. |
Research Applications
Key Research Applications
Chonluten is commonly discussed in controlled research models involving EDG tripeptide activity, respiratory tissue signaling, bronchial mucosa cell function, inflammatory-response pathways, antioxidant protein expression, gene-expression regulation, and pulmonary epithelial research context.
Peptide Bioregulator Research
Chonluten is commonly positioned within ultrashort peptide bioregulator research, where short peptide sequences are studied for gene-expression and tissue-specific signaling effects.
Respiratory Tissue Models
Chonluten is commonly discussed in respiratory research contexts involving lung tissue, bronchial mucosa, and pulmonary epithelial cell-response models.
Bronchial Mucosa Research
Used in research discussions involving bronchial mucosa cell function, mucosal tissue signaling, and airway-associated cellular response documentation.
Inflammatory Signaling
Chonluten research is commonly framed around inflammatory-response models, including cytokine-related pathways and tissue-stress response markers.
Antioxidant Response Models
T-34 has been discussed in research involving antioxidant and anti-inflammatory protein expression, oxidative-stress context, and cellular protection markers.
Gene-Expression Research
As an ultrashort tripeptide, Chonluten may be studied in gene-expression, transcriptional-response, protein-synthesis, and tissue-specific regulatory models.
Research Scope
These applications are provided for educational and research-reference purposes only. Chonluten research is limited compared with larger peptide categories, and outcomes may vary based on sequence identity, purity, model type, concentration, exposure duration, tissue model, and laboratory conditions.
Reference Only
Reconstitution / Research Dosing Reference
Quick Reference Summary
| Reference Vial | 20 mg Chonluten |
|---|---|
| Primary Solution Volume | 1.0 mL bacteriostatic water |
| Primary Concentration | 20 mg/mL |
| Measurement Reference | On a U-100 syringe, 1 unit = 0.01 mL. |
| Amount per U-100 Unit | At 20 mg/mL, 1 unit equals 0.2 mg / 200 mcg Chonluten. |
| Storage Reference | Refrigerate at 2–8°C / 35.6–46.4°F after reconstitution, protected from direct light. |
Reconstitution Steps
- Draw 1.0 mL bacteriostatic water using a sterile syringe for the main concentration reference shown below.
- Slowly add the BAC water down the side of the vial wall.
- Gently roll or swirl the vial until the material is completely dissolved. The solution should appear clear to slightly hazy depending on concentration and supplier format. Do not shake!
- Because this is a concentrated 20 mg/mL preparation, verify complete dissolution before recording final preparation details.
- Label with compound name, vial amount, concentration, solvent volume, preparation date, storage conditions, and handling notes.
- Store refrigerated at 2–8°C / 35.6–46.4°F, protected from direct light.
Published Research Context
| Reference Type | Reported Amount / Context | Research Notes |
|---|---|---|
| Compound Identity Reference | Chonluten, commonly referenced as EDG / Glu-Asp-Gly | Chonluten is commonly discussed as a short synthetic tripeptide bioregulator associated with bronchial epithelial, pulmonary-tissue, and tissue-specific regulatory research contexts. |
| Peptide Bioregulator Research | Model-dependent concentration and endpoint tracking | Commonly discussed in short-peptide bioregulator, DNA / chromatin interaction, gene-expression, cellular-response, inflammatory-marker, and tissue-specific marker documentation. |
| Bronchial / Pulmonary Research Context | Bronchial epithelial cell and respiratory-tissue model context | Chonluten-related research discussions commonly include bronchial mucosa, respiratory epithelium, pulmonary tissue markers, epithelial-cell response, and tissue-specific regulatory observations. |
| Inflammatory-Marker Research | THP-1 monocyte / macrophage and cytokine-marker context | Published research has discussed Chonluten in relation to inflammatory and proliferative activity in THP-1 monocyte/macrophage models, including TNF production observations. |
| Oxidative-Stress Research Context | Cellular stress-response and antioxidant-marker context | Research discussions commonly include oxidative-stress markers, antioxidant-response pathways, cellular stress response, epithelial integrity, and tissue-resilience marker tracking. |
| Gene-Expression Research Context | Short peptide / gene-expression marker context | Short peptide bioregulator literature commonly discusses DNA interaction, regulatory sequence context, chromatin structure, and changes in gene-expression marker patterns depending on the model. |
| Public Protocol-Style Reference | Milligram-range reference examples | Public protocol-style references commonly describe Chonluten in milligram-range examples. These are not clinical dosing standards. |
| Clinical / Research-Chemical Status | No universal research-chemical protocol established | Published study references, public protocol-style references, clinical-use references, or wellness protocols should not be treated as dosing instructions for research-chemical vial formats. |
Concentration Reference
| Vial Amount | Solution Volume | Final Concentration |
|---|---|---|
| 20 mg | 1.0 mL | 20 mg/mL |
Research Dosing Amount / Volume Reference
| Reference Amount | Volume at 20 mg/mL | U-100 Unit Reference | Approx. References per 20 mg Vial |
|---|---|---|---|
| 0.5 mg / 500 mcg | 0.025 mL | 2.5 units | 40 |
| 1 mg / 1000 mcg | 0.05 mL | 5 units | 20 |
| 2 mg / 2000 mcg | 0.10 mL | 10 units | 10 |
| 5 mg / 5000 mcg | 0.25 mL | 25 units | 4 |
| 10 mg / 10000 mcg | 0.50 mL | 50 units | 2 |
| 20 mg / 20000 mcg | 1.00 mL | 100 units | 1 |
Research Frequency / Amount Reference
| Research Window | Frequency | Reference Amount | Units / Volume Reference |
|---|---|---|---|
| Lower Conversion Reference | Public protocol-style reference, not a clinical dosing standard | 0.5 mg reference amount | 2.5 units / 0.025 mL |
| Standard Conversion Reference | Public protocol-style reference, not a clinical dosing standard | 1 mg reference amount | 5 units / 0.05 mL |
| Mid-Range Conversion Example | Calculation reference only | 2 mg reference amount | 10 units / 0.10 mL |
| Upper Conversion Example | Calculation reference only | 5 mg reference amount | 25 units / 0.25 mL |
| High Conversion Example | Calculation reference only | 10 mg reference amount | 50 units / 0.50 mL |
| Full-Vial Preparation Reference | Preparation-level calculation reference | 20 mg reference amount | 100 units / 1.00 mL |
Common Research Windows
| Reference Window | Common Length | Research Notes |
|---|---|---|
| Cell-Culture / Bronchial Marker Window | 24–72 hours | May be used for bronchial epithelial response, inflammatory-marker, cytokine-marker, oxidative-stress marker, gene-expression, or peptide-response documentation depending on the model. |
| Acute Respiratory-Tissue Observation Window | Single session to several days | Used for early response tracking, cytokine-marker comparison, oxidative-stress marker observation, or short-term pathway documentation depending on the research design. |
| Short Research Window | 1–2 weeks | May be used for short-duration controlled observation involving bronchial mucosa, pulmonary-tissue, respiratory epithelium, or inflammatory-marker endpoints. |
| Standard Protocol-Style Window | 2–4 weeks | Commonly used in public protocol-style references for structured observation and comparison across baseline and follow-up periods. |
| Extended Observation Window | 4–8 weeks | Used when longer documentation is needed for tissue-specific marker trends, inflammatory-marker comparison, oxidative-stress marker tracking, or follow-up marker documentation. |
| Follow-Up / Washout | 1–4 weeks | Used to document post-study observations, marker return, delayed response patterns, or follow-up data depending on the research model. |
Research Note: These tables are provided for educational, research-planning, concentration, frequency-reference, and volume-reference purposes only. Chonluten, commonly referenced as EDG / Glu-Asp-Gly, is discussed in peptide bioregulator, bronchial epithelial, pulmonary-tissue, respiratory epithelium, inflammatory-marker, cytokine-marker, TNF-production, oxidative-stress-marker, gene-expression, and tissue-specific regulatory research contexts. This reference uses a 20 mg vial reconstituted with 1.0 mL bacteriostatic water, creating a 20 mg/mL concentration. Higher-concentration preparations may require supplier-specific handling, solvent-volume, or solubility notes; verify against the COA, batch record, or formula record when available. Published study references and public protocol-style frequency references are not universal research-chemical dosing standards and should not be treated as dosing instructions for research-chemical vial formats. This information is not medical advice, dosing instruction, injectable-use guidance, or a recommendation for human or animal use.
Research Notes
Research Findings & Safety Notes
Research Findings
Chonluten is commonly discussed in research involving ultrashort peptide bioregulation, EDG tripeptide signaling, respiratory tissue model context, bronchial mucosa cell function, antioxidant protein expression, inflammatory-response pathways, and gene-expression regulation.
Study Limitations
Chonluten research is limited compared with major peptide categories and includes peptide bioregulator, gene-expression, inflammatory-response, and respiratory tissue model references. Findings should be interpreted according to peptide sequence, purity, model type, concentration, exposure duration, and endpoint selection.
Safety Considerations
Research discussion should account for peptide identity verification, sequence confirmation, sterility documentation, endotoxin risk, supplier qualification, batch records, storage conditions, and qualified laboratory handling procedures.
Use Restriction
Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease when discussed as a research-use material.
Related Supplies
Research Supplies
For research supplies, visit our affiliate partner and use code PLHQ10 to save 10% on your order.
Bacteriostatic Water
Commonly referenced in laboratory preparation workflows.
Research Syringes
Supply category for controlled laboratory research preparation.
Prep Supplies
Supporting supplies for clean handling, preparation, and documentation.
Lab Handling
Handling & Storage
Storage
Store materials according to product-specific requirements. Protect from excessive heat, moisture, and direct light.
After Reconstitution
Keep refrigerated after reconstitution unless otherwise specified by the product documentation.
Handling
Use appropriate laboratory PPE, clean handling practices, and qualified research procedures.
Documentation
Maintain batch details, COA records, preparation notes, and internal research documentation.